APLS Apellis Pharmaceuticals: Earnings growth forecast for next year

Corporate company logo of apellis.com (APLS)

Geopolitical fragmentation complicates the cross-border export of biotechnologies, yet the chart of consensus EPS growth estimates for next year demonstrates resilience for Apellis Pharmaceuticals (APLS). The current level sits around 74.80, supported by the expansion of Syfovre and the introduction of C3 therapy into neurology. Supply chain stability guarantees temperature control during drug delivery via global biomedical operators, ensuring an uninterrupted supply to ophthalmology centers.

Apellis Pharmaceuticals, Inc. (APLS): Net earnings per share change forecast for next year from 07/04/2022 to 05/30/2026

Comprehensive metric breakdowns and analytics for apellis.com (APLS)

- price and consensus price forecast:
Price Chart Apellis Pharmaceuticals Inc|APLS - Analyst Median Target
- company stock capitalization data:
Market Capitalization Apellis Pharmaceuticals|APLS - Enterprise Value
- book capitalization indicators:
Net Assets per Single Share Apellis Pharmaceuticals|APLS - Net Asset Value|Market Capitalization to Book Value Ratio apellis.com|APLS - Company Assets
- debt and liquidity details:
Debt to Equity Apellis Pharmaceuticals|APLS - Long-Term Debt to Equity|Short-Term Debt to Equity Apellis|APLS - Company Debts|Debts to Book Capitalization Apellis Pharmaceuticals|APLS - Long-Term Debt Volume|Company Short-Term Debt Apellis Pharmaceuticals|Quick Liquidity Indicator apellis.com
- net income and valuation ratios data:
APLS - Final Profit|Expected Profit Apellis Pharmaceuticals|APLS - Market Cap to Net Income|Forward P/E Multiple Apellis Pharmaceuticals|APLS - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Apellis Pharmaceuticals|APLS - Operating profit EBITDA|Earnings per share for the last twelve months Apellis Pharmaceuticals|APLS - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months apellis.com|APLS - Net earnings per share growth this year|Earnings growth forecast for next year Apellis Pharmaceuticals
Summary company analysis:Apellis Pharmaceuticals Inc, APLS
Core merchandise of Apellis

Investors assess the reliability of the issuer through market expectation trends, utilizing forward multiples to verify business sustainability. This projection of net income per share growth for year n+1 reflects analyst consensus estimates, where high volatility in the trend line indicates uncertainty regarding insurance coverage and clinical recognition of Apellis Pharmaceuticals (APLS) drugs, signaling increased risks of a deep price drawdown.

Competitor analysis

Net earnings per share growth forecast for next year Alcon Vision|Bausch Health (BLCO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GKOS|Earnings growth forecast for next year Belite Bio, Inc. (BLTE)|Net earnings per share growth forecast for next year Ocular Therapeutix, Inc. OCUL|HROW (Harrow Inc) - Net earnings per share change forecast for next year|Viridian Pharma - Earnings growth forecast for next year|Expected net earnings per share growth next year LENZ Corp|oculis.com (OCS) - Net earnings per share growth forecast for next year|EYPT (eyepointpharma.com) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Kodiak Sciences|Net earnings per share growth forecast for next year ALDX|Earnings growth forecast for next year KALA|Consensus forecast of earnings per share growth for next year opusgtx.com|Net earnings per share growth forecast for next year OKYO Pharma OKYO|Consensus forecast of earnings per share growth for next year Adverum Biotechnologies Inc. (ADVM)|OTLK: Expected earnings per share growth for next year|Expected earnings per share trend next year CLSD (Clearside Biomedical Inc)|novabay.com (NBY) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year KPRX (Kiora Pharmaceuticals, Inc.)|ALIM (Alimera Sciences Inc) - Earnings growth forecast for next year|EYEN: Expected earnings per share trend next year|Earnings growth forecast for next year GHSI|Earnings growth forecast for next year Ocuphire Pharma Inc (OCUP)|Net earnings per share growth forecast for next year Opthea Ltd. OPT